MAP kinase phosphorylation‐dependent activation of Elk‐1 leads to activation of the co‐activator p300
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
CBP/p300 recruitment to enhancer-bound complexes is a key determinant in promoter activation by many transcription factors. We present a novel mechanism of activating such complexes and show that pre-assembled Elk-1-p300 complexes become activated following Elk-1 phosphorylation by changes in Elk-1-p300 interactions rather than recruitment. It is known that Elk-1 binds to promoter in the absence of stimuli. However, it is unclear how activation of Elk-1 by mitogen-acivated protein kinase (MAPK)-mediated phosphorylation leads to targeted gene transactivation. We show that Elk-1 can interact with p300 in vitro and in vivo in the absence of a stimulus through the Elk-1 C-terminus and the p300 N-terminus. Phosphorylation on Ser383 and Ser389 of Elk-1 by MAPK enhances this basal binding but, most importantly, Elk-1 exhibits new interactions with p300. These interaction changes render a strong histone acetyltransferase activity in the Elk-1-associated complex that could play a critical role in chromatin remodeling and gene activation. The pre-assembly mechanism may greatly accelerate transcription activation, which is important in regulation of expression of immediate-early response genes, in particular those involved in stress responses.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ELK1 binds p300, and Ras/MAP-kinase-dependent phosphorylation within a transactivation domain enhances the interaction (89, 114–116).”
From Genomic and biochemical insights into the specificity of ETS transcription factors (2011) · cites this paper as [115]
Citations
Cites
Cofactor Dynamics and Sufficiency in Estrogen Receptor–Regulated Transcription
Shang, Y., Hu, X., DiRenzo, J., Lazar, M. A., & Brown, M. (2000) · Cell · doi:10.1016/s0092-8674(00)00188-4 · Cited by 1,657
Yao, T.-P., Oh, S. P., Fuchs, M., Zhou, N.-D., Ch'ng, L.-E., Newsome, D., Bronson, R. T., Li, E., Livingston, D. M., & Eckner, R. (1998) · Cell · doi:10.1016/s0092-8674(00)81165-4 · Cited by 1,014
Coactivator and corepressor complexes in nuclear receptor function
Xu, L., Glass, C. K., & Rosenfeld, M. G. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80021-5 · Cited by 902
CREB-binding Protein and p300 in Transcriptional Regulation
Vo, N., & Goodman, R. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r000025200 · Cited by 866
Recruitment of p300/CBP in p53-Dependent Signal Pathways
Avantaggiati, M. L., Ogryzko, V., Gardner, K., Giordano, A., Levine, A. S., & Kelly, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80304-9 · Cited by 669
ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation.
Gille, H., Kortenjann, M., Thomae, O., Moomaw, C., Slaughter, C., Cobb, M. H., & Shaw, P. E. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb07076.x · Cited by 664
Activation of ternary complex factor Elk-1 by MAP kinases.
Janknecht, R., Ernst, W. H., Pingoud, V., & Nordheim, A. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06204.x · Cited by 560
Gene dose-dependent control of hematopoiesis and hematologic tumor suppression by CBP
Kung, A. L., Rebel, V. I., Bronson, R. T., Ch'ng, L.-E., Sieff, C. A., Livingston, D. M., & Yao, T.-P. (2000) · Genes & Development · doi:10.1101/gad.14.3.272 · Cited by 440
CBP: A Signal-Regulated Transcriptional Coactivator Controlled by Nuclear Calcium and CaM Kinase IV
Chawla, S., Hardingham, G. E., Quinn, D. R., & Bading, H. (1998) · Science · doi:10.1126/science.281.5382.1505 · Cited by 425
Janknecht, R., & Hunter, T. (1996) · Nature · doi:10.1038/383022a0 · Cited by 393
Cited by
Items 101–161 of 161
Thyroid transcription factor FOXE1 interacts with ETS factor ELK1 to co-regulate TERT
Bullock, M., Lim, G., Li, C., Choi, I. H., Kochhar, S., Liddle, C., Zhang, L., & Clifton-Bligh, R. J. (2016) · Oncotarget · doi:10.18632/oncotarget.13288 · Cited by 21
Epidermal growth factor regulates PAI-1 expression via activation of the transcription factor Elk-1
Wyrzykowska, P., Stalińska, K., Wawro, M., Kochan, J. A., & Kasza, A. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.08.004 · Cited by 26
Message in a nucleus: signaling to the transcriptional machinery
Carrera, I., & Treisman, J. E. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.07.007 · Cited by 20
Nandiwada, S. L., Li, W., Zhang, R., & Mueller, D. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.401 · Cited by 20
“However, wildtype Elk-1 (but not mutated Elk-1 protein lacking serines at aa 383 and 389) demonstrates significantly enhanced in vitro binding to the N-terminal p3001514–1922 protein sequence following phosphorylation by ERK2 (56).”
BackgroundThiel, G., Backes, T. M., Guethlein, L. A., & Rößler, O. G. (2021) · Molecules · doi:10.3390/molecules26206125 · Cited by 22
“Kinetic studies have shown that the EGF-induced phosphorylation of Elk-1 on serine residue S383 is already strongly visible 15 min after stimulation, whereas after 60 min much lower levels of phospho-Elk-1 are detected [5,53].”
BackgroundHuang, E., Zhao, Y., Chen, G., Baek, S. J., McEntee, M. F., Minkin, S. C., Biggerstaff, J., & Whelan, J. N. (2014) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-14-68 · Cited by 19
“Data are presented as the mean ± SD, n = 3. histone acetyltransferase activity of CBP/p300 can be regulated upstream by Erk1/2 and its downstream regulator, Elk-1 [38,58].”
InfluentialAdiseshaiah, P. P., Kalvakolanu, D. V., & Reddy, S. P. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7193 · Cited by 20
Euhus, D., Bu, D., Xie, X.-J., Sarode, V. R., Ashfaq, R., Hunt, K. K., Xia, W., O’Shaughnessy, J., Grant, M., Arun, B. K., et al. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0186 · Cited by 19
“plexes (33,34), suggesting a possible mechanism for the decrease in tumor suppressor gene methylation observed with tamoxifen.”
Signal-induced PARP1-Erk synergism mediates IEG expression
Cohen‐Armon, M., Yeheskel, A., & Pascal, J. M. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0042-0 · Cited by 21
Shi, L., Song, L., Maurer, K., Dou, Y., Patel, V. R., Su, C., Leonard, M. E., Lu, S., Hodge, K. M., Torres, A., et al. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900650 · Cited by 18
“Several studies identified a role for MAPK in activating p300 binding in very specific settings, but it is not yet clear if MAPKs represent the major pathway for p300 activation (55, 74, 75).”
BackgroundLei, J., Chen, S., & Zhong, S. (2017) · Liver Research · doi:10.1016/j.livres.2017.08.005 · Cited by 17
Mostocotto, C., Carbone, M., Battistelli, C., Ciotti, A., Amati, P., & Maione, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102575 · Cited by 18
“Acetylation of core histones is generally enriched at the 59 of actively transcribed genes [28] and in some experimental settings it has been found to be a downstream effect of ERK signaling [13,29,30].”
BackgroundCellular stress triggers TEL nuclear export via two genetically separable pathways
Hanson, C. A., Wood, L. D., & Hiebert, S. W. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21637 · Cited by 17
“ETS family members such as Elk-1 are also phosphorylated by p38 and this modification stimulates the ability of Elk-1 to activate transcription [Janknecht and Nordheim, 1996; Enslen et al., 1998; Li et al., 2003].”
BackgroundZhao, H., Chen, M., Wang, J., Cao, G., Chen, W., & Xu, J. (2020) · Aging · doi:10.18632/aging.102991 · Cited by 15
“Consistent with previous reports [31, 32], our findings combined with previous studies suggest that the abnormal activation of ELK1 by MAPK may play an important role in KIAA0101 overexpression in the human NPC progression (Figure 8).”
ResultRegulation of thrombin-induced plasminogen activator inhibitor-1 in 4T1 murine breast cancer cells
McEachron, T. A., Church, F., & Mackman, N. (2011) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0b013e3283497647 · Cited by 16
Jin, Y., Norquay, L., Yang, X., Gregoire, S., & Cattini, P. A. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0405 · Cited by 18
Interplay of the SUMO and MAP Kinase Pathways
Yang, S., & Sharrocks, A. D. (2006) · Springer eBooks · doi:10.1007/3-540-37633-x_11 · Cited by 14
Self-citationPro-proliferative function of the long isoform of PML-RARα involved in acute promyelocytic leukemia
Tussié-Luna, M. I., Rozo, L., & Roy, A. L. (2006) · Oncogene · doi:10.1038/sj.onc.1209388 · Cited by 15
“Removal of HDAC3 in response to growth factor signaling could thus, allow recruitment of co-activators like CBP/p300, which is known to interact with Elk/ TCF and be recruited to the c-fos promoter (Nissen et al., 2001; Li et al., 2003).”
BackgroundIdentification of trophoblast‐specific elements in the HLA‐C core promoter
Johnson, J. K., Wright, P. W., Li, H., & Anderson, S. K. (2018) · HLA · doi:10.1111/tan.13404 · Cited by 14
“Because CIITA is not expressed in trophoblasts, and it cannot be induced by IFN-γ,(20) the altered RFX site of the HLA-C gene may recruit the CBP/p300 coactivators via ETS molecules in trophoblasts.(21,22)”
BackgroundMolecular and Epigenetic Mechanisms Underlying Cognitive and Adaptive Responses to Stress
Trollope, A. F., Mifsud, K. R., Saunderson, E. A., & Reul, J. M. H. M. (2017) · Epigenomes · doi:10.3390/epigenomes1030017 · Cited by 13
“Importantly, it was found that activation of the NMDA-R/ERK1/2/MSK1/2-ELK1 signaling pathway was critical for the consolidation of the behavioral immobility response [13,27,33].”
BackgroundInfluentialGao, W., Pan, B., Liu, L., Huang, X., Liu, Z., & Tian, J. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.09.090 · Cited by 12
Fan, L., Jiang, L., & Du, Z. (2015) · Metabolic Brain Disease · doi:10.1007/s11011-015-9703-z · Cited by 12
“MPP+ has been extensively used in a variety of in vivo and in vitro systems to model PD. Phosphorylation of Elk-1 is thought to enable Elk1 to mediate transcriptional activation (Li et al. 2003).”
Soeung, M., Yan, X., Zanca, C., Qian, J., Karki, M., Duan, F., Khan, H., Zhang, L., Peng, D. H., Williams, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65462-z · Cited by 13
In-depth proteomic profiling captures subtype-specific features of craniopharyngiomas
Kim, J. H., Kim, H., Dan, K., Kim, S., Park, S., Han, D., & Kim, Y. H. (2021) · Scientific Reports · doi:10.1038/s41598-021-00483-4 · Cited by 11
Chromatin-embedded reporter genes: Quantification of stimulus-induced gene transcription
Thiel, G., Backes, T. M., Guethlein, L. A., & Rößler, O. G. (2021) · Gene · doi:10.1016/j.gene.2021.145645 · Cited by 10
Lim, S., Lim, J., Lee, A., Yang, Y. D., Kim, K. I., & Lim, J. (2023) · Cancers · doi:10.3390/cancers15215270 · Cited by 9
“Specifically, the phosphorylation of Elk-1 by MAPK leads to interaction with p300, yielding Elk-1-p300 complexes, which play a crucial role in gene activation and chromatin remod-Cancers eling [35].”
BackgroundIslam, T., Majumder, M., Kalita, B., Bhattacharjee, A., Mukhopadhyay, R., & Mukherjee, A. K. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15153 · Cited by 8
“In the MAPK pathway, p38 and ERK1/2 are key proteins, and their activation (phosphorylation) carries the signal forward into the nucleus, subsequently regulating the activity of many transcription factors including ETS domain-containing protein ELK1 (Li et al., 2003).”
BackgroundLim, J. H., Cho, J., Park, Y. B., Park, J., & Kwon, T. K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.102 · Cited by 8
A Long-Lasting PARP1-Activation Mediates Signal-Induced Gene Expression
Cohen‐Armon, M. (2022) · Cells · doi:10.3390/cells11091576 · Cited by 8
MAP Kinase: SUMO Pathway Interactions
Yang, S., & Sharrocks, A. D. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-795-2_21 · Cited by 8
Self-citationKurnaz, I. A. (2004) · Biotechnology and Bioengineering · doi:10.1002/bit.20322 · Cited by 10
Ducker, C. E., Ratnam, M., Shaw, P. E., & Layfield, R. (2022) · Protein Expression and Purification · doi:10.1016/j.pep.2022.106216 · Cited by 8
The Role of Peptidyl Arginine Deiminase IV(PADI4) in Cancers
Wang, W., Wu, X., & Wang, Y. (2022) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520622666220614115309 · Cited by 7
Targeting MEK in cancer and beyond: mechanistic insights and therapeutic opportunities
Chan, W. Y., da Silva, I. P., Long, G. V., & Rizos, H. (2026) · The Lancet · doi:10.1016/s0140-6736(26)00199-6 · Cited by 6
Epigenetic Mechanisms in Memory Formation
Reul, J. M. H. M., Collins, A., & Gutièrrez‐Mecinas, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-17426-1_14 · Cited by 5
Wei, X., Yu, L., Jin, X., Song, L., Lv, Y., & Han, Y. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9193 · Cited by 6
“ELK1, a known carcinogenic factor, is able to stimulate transcription from the c-fos serum response element or from an ETS binding site (38).”
TRPM3-Induced Gene Transcription Is under Epigenetic Control
Thiel, G., & Rößler, O. G. (2022) · Pharmaceuticals · doi:10.3390/ph15070846 · Cited by 4
“This study supports previous investigations showing that stimulus-activated transcription of target genes involving AP-1, CREB, or Elk-1 requires CBP and/or p300 activity [19,29].”
ResultA PARP1-Erk2 synergism is required for stimulation-induced expression of immediate early genes
Cohen‐Armon, M. (2016) · PubMed · doi:10.13140/rg.2.1.4705.1767 · Cited by 4
Stress-activated MAP Kinases in Chromatin and Transcriptional Complexes
Crump, N. T., Han, Y. T., & Mahadevan, L. C. (2007) · Springer eBooks · doi:10.1007/4735_2007_0254 · Cited by 2
“Similarly, mammalian SAPKs phosphorylate sequence-specific transcription factors to mediate recruitment of histone acetyltransferase (HAT) activities to gene promoters (Fig. 2). For example, the ternary complex factor (TCF) family protein Elk-1 is phosphorylated by both JNK/SAPK1 and p38/SAPK2 ( Li et al. 2003 ), recr…”
BackgroundBahrami, M., Abbaszadeh, H., Berjis, K., & Moradi, A. (2026) · BioMed Research International · doi:10.1155/bmri/4137354 · Cited by 1
“Once phosphorylated in the nucleus, activated MAPKs regulate various transcription factors, including Elk-1 [100, 101].”
Lei, J., Chen, S., & Zhong, S. (2017) · Liver Research · doi:10.1016/j.livres.2017.08.006 · Cited by 1
Odrowaz, Z., & Sharrocks, A. D. (2011) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a000830.01 · Cited by 1
Self-citationXia, Y., Yang, Y. T., Liu, Y., Cheng, J., Liu, Y., Li, C., & Liu, P. (2024) · Marine Biotechnology · doi:10.1007/s10126-024-10296-x · Cited by 1
“The other two key node methylation genes identified by us include myca and tp53 , which have been identified as sub-strategies of MAPK (Li et al. 2003; Hernandez-Hernandez et al. 2006; Sears et al. 2000; Persons et al. 2000).”
Contrôle du trafic intracellulaire de Elk-1 par SUMO
Salinas, S., & Hipskind, R. A. (2005) · médecine/sciences · doi:10.1051/medsci/2005212121 · Cited by 1
“La phosphorylation activatrice d’Elk-1 mènerait, d’une part, à sa « déSUMOylation » et donc à la perte de liaison de l’HDAC-2 et, d’autre part, au recrutement du co-activateur CBP ou p300 [6, 7].”
Kerkelä, R. (2003) · Cited by 1
In-depth Proteomic Profiling Captures Subtype-specific Features of CraniopharyngiomasPreprint
Kim, J. H., Kim, H., Dan, K., Kim, S., Park, S., Han, D., & Kim, Y. H. (2021) · Research Square · doi:10.21203/rs.3.rs-666783/v1 · Cited by 1
Reul, J. M. H. M., Collins, A., & Gutièrrez‐Mecinas, M. (2011) · Wiley eBooks · doi:10.1002/9781118083222.ch5
Role of androgen receptor in folate receptor α regulation and in prostate cancer
Sivakumaran, S. (2012) · OhioLink ETD Center (Ohio Library and Information Network)
SIGNALING PATHWAYS IN MYOCYTE HYPERTROPHY
Oulu, B. (2003)
CBP/p300 Recruitment Signaling Activates Ets-1 and Ets-2 by Ras/Mitogen-Activated Protein Kinase
Graves, B. J., Foulds, C. E., Nelson, M. L., & Blaszczak, A. G. (2014)
Epigenetics of Glucocorticoid Action
Mifsud, K. R., Carter, S. D., Linthorst, A. C. E., & Reul, J. M. H. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803592-4.00046-8 · Cited by 1
Chapter 11 Zyfl amend and Prostate Cancer Therapy
Whelan, J. N., Zhao, Y., Huang, E., MacDonald, A., & Donohoe, D. R. (2016) · Traditional herbal medicines for modern times · doi:10.1201/9781315370156-12 · Cited by 1
Chiang, C. (2010) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.2152956.1756055
Euhus, D., Bu, D., Xie, X.-J., Sarode, V. R., Ashfaq, R., Hunt, K. K., Xia, W., O’Shaughnessy, J., Grant, M., Arun, B., et al. (2023) · doi:10.1158/1940-6207.c.6544613
Euhus, D., Bu, D., Xie, X.-J., Sarode, V. R., Ashfaq, R., Hunt, K. K., Xia, W., O’Shaughnessy, J., Grant, M., Arun, B., et al. (2023) · doi:10.1158/1940-6207.22525187
Methylation specifies distinct estrogen-induced binding site repertoires of CBP to chromatin
Walia, M. (2012) · theses.fr (ABES) · doi:10.70675/792f626dzc3bcz4949z83e1z99da9678a4e2
Symington, H. L. (2016) · theses.fr (ABES) · doi:10.70675/42fb5e2cz3a02z4d3cz8070zea229b24b4b3
Metadata
- Authors
- Li, Q., Yang, S., Maeda, Y., Sladek, F. M., Sharrocks, A. D., & Martins‐Green, M.
- Affiliations
- University of Manchester (GB)
- University of California, Riverside (US)
- Corresponding author
- Martins‐Green, Manuela
- Venue
- The EMBO Journal
- Published
- 2003-01-15
- Volume
- 22
- Issue
- 2
- Pages
- 281-291
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC140103
- OpenAlex
- W2125049729
- Cited by
- 158
- References
- 31
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1 · 2023: 5 · 2022: 6 · 2021: 6 · 2020: 7 · 2019: 1 · 2018: 3 · 2017: 6 · 2016: 11 · 2015: 5 · 2014: 7 · 2013: 4 · 2012: 3
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- The EMBO Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- American Heart Association
- Wellcome Trust
- Lister Institute of Preventive Medicine
- National Institute of General Medical Sciences
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK053892)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- Elk-1, P300, MAPK phosphorylation, histone acetyltransferase activity, chromatin remodeling, immediate early genes, stress response genes, transcriptional activation
- MeSH terms
- Acetyltransferases, Animals, Chick Embryo, DNA-Binding Proteins, Enzyme Inhibitors, Fibroblasts, Models, Biological, Nuclear Proteins, Phosphorylation, Promoter Regions, Genetic, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Thrombin, Transcription Factors, Transcriptional Activation, Trans-Activators, Mitogen-Activated Protein Kinases, Saccharomyces cerevisiae Proteins, ets-Domain Protein Elk-1, Histone Acetyltransferases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.